NCT05245227: Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- State
- Under way
- Phase
- Phase 3
- People
- 1,358 planned
- Started
- 27 Jan 2025
- Primary completion
- 1 Jan 2027
- Arms
- Misoprostol plus intravenous Oxytocin
- Results
- None posted
- 17 Feb 2022: Trial registered
- 27 Jan 2025: Trial started